8-K
Current Report
Celldex Therapeutics, Inc. Filed Acc 0001157523-07-003574
Exit or restructuring costs
- Item 2.05 Costs associated with exit or disposal activities
From the SEC's structured data for this filing
Loading a5377117.txt…